FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 126 filers reported holding FATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $617,000 | -71.4% | 24,918 | -55.3% | 0.00% | -50.0% |
Q1 2022 | $2,160,000 | -32.5% | 55,724 | +2.3% | 0.00% | 0.0% |
Q4 2021 | $3,200,000 | +71.3% | 54,469 | +72.8% | 0.00% | +100.0% |
Q3 2021 | $1,868,000 | -29.2% | 31,524 | +3.7% | 0.00% | -50.0% |
Q2 2021 | $2,640,000 | -28.3% | 30,413 | -31.9% | 0.00% | -50.0% |
Q1 2021 | $3,680,000 | -11.3% | 44,644 | -2.1% | 0.00% | 0.0% |
Q4 2020 | $4,147,000 | +489.9% | 45,608 | +44.0% | 0.00% | +300.0% |
Q1 2020 | $703,000 | -19.5% | 31,670 | -29.0% | 0.00% | 0.0% |
Q4 2019 | $873,000 | +28.0% | 44,601 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $682,000 | -69.1% | 43,947 | -59.5% | 0.00% | -50.0% |
Q2 2019 | $2,204,000 | +14.5% | 108,566 | -0.9% | 0.00% | 0.0% |
Q1 2019 | $1,925,000 | +38.5% | 109,549 | +1.1% | 0.00% | 0.0% |
Q4 2018 | $1,390,000 | -21.1% | 108,361 | +0.2% | 0.00% | 0.0% |
Q3 2018 | $1,761,000 | +5580.6% | 108,132 | +492.4% | 0.00% | – |
Q2 2016 | $31,000 | -91.3% | 18,252 | -90.8% | 0.00% | – |
Q1 2016 | $355,000 | -49.6% | 197,329 | -5.7% | 0.00% | -100.0% |
Q4 2015 | $705,000 | -31.4% | 209,307 | +8.7% | 0.00% | 0.0% |
Q3 2015 | $1,027,000 | – | 192,596 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |